Overall Score

Profitability Returns

IRMD continues to generate strong returns on capital, with ROIC at 20.2%, ROE at 23.5%, and ROA at 20.1%.

Operating margins remain healthy, with EBIT margin at 33.9% and EBITDA margin at 36.0%.

Gross margin is still very high at 75.9%, supporting a durable economics profile.

Balance Sheet Strength

The balance sheet remains exceptionally strong with zero debt and a current ratio of 9.46x.

Net debt to EBITDA is -1.90x, indicating a net cash position and substantial financial flexibility.

Cash generation and liquidity remain robust, with cash ratio at 6.45x and operating cash flow ratio at 2.96x.

Cash Flow Quality

Free cash flow conversion remains solid, with free cash flow at 91.9% of operating cash flow.

Operating cash flow margin is 31.4%, supporting consistent cash generation.

Capital intensity remains modest, with capex at 2.6% of revenue and capex coverage at 12.3x.

Competitive Position

High gross margins and strong returns suggest a differentiated niche position, but the data alone does not prove a wide moat.

The company’s premium valuation (EV/Sales 12.2x and EV/EBITDA 33.9x) implies the market already prices in durable advantages.

No recent news was provided this month, so there is no new evidence of moat expansion or erosion.